Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from China Shineway Pharmaceutical Group Limited ( (HK:2877) ).
China Shineway Pharmaceutical Group Limited, a company incorporated in the Cayman Islands, has announced changes to its Board of Directors, effective from 10 June 2025. The board will consist of executive directors Li Zhenjiang, Xin Yunxia, and Li Huimin, independent non-executive directors Liu Shun Fai, Yew Yat On, and Wang Guihua, and non-executive director Zhou Wencheng. The announcement also details the membership of the board committees, which are crucial for the company’s governance and strategic direction.
More about China Shineway Pharmaceutical Group Limited
Average Trading Volume: 1,309,305
Technical Sentiment Signal: Hold
Current Market Cap: HK$5.65B
See more data about 2877 stock on TipRanks’ Stock Analysis page.